[1]
H. P. Eikesdal, S. Knappskog, T. Aas, and P. E. Lønning, “TP53 status predicts long-term survival in locally advanced breast cancer after primary chemotherapy”, AO, vol. 53, no. 10, pp. 1347–1355, Oct. 2014.